Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4 Neoplasm Metastasis 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Small Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid, Chronic-Phase 2 Glioblastoma 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Vaping 1 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Stomach Neoplasms 1 Solid Tumor 1 Peripheral Nervous System Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Neoplasms by Histologic Type 1 NSCLC 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid 1 Leukemia 1 Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1

Interventions

Varenicline 1 Transdermal Patch 1 Standard of Care 1 Nicotine Replacement Therapy 1 Early Intervention, Educational 1 BID protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Vaping × BID protein, human × Clear all

NCT07040566 2025-12-17

A Trial of Varenicline for E-cigarette Cessation

Yale University

Phase 2 Recruiting

Vaping, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon ⚡